Trihydroxyoctadecadienoic acids exhibit antiatherosclerotic and antiatherogenic activity

A standardized mixture of isomeric trihydroxy fatty acids (TFA: 12,13,16-trihydroxy-9Z, 14E-octadecadienoic-, 12,15,16-trihydroxy-9Z, 13E-octadecadienoic-, 9,10,13-trihydroxy-HE, 15Z-octadecadienoic-, and 12,13,16-trihydroxy-9,14Z-octadecadienoic acid), isolated from Bryonia alba L. roots, were foun...

Full description

Saved in:
Bibliographic Details
Published inPhytomedicine (Stuttgart) Vol. 1; no. 2; p. 123
Main Authors Orekhov, A N, Panossian, A G
Format Journal Article
LanguageEnglish
Published Germany 01.09.1994
Online AccessGet more information

Cover

Loading…
More Information
Summary:A standardized mixture of isomeric trihydroxy fatty acids (TFA: 12,13,16-trihydroxy-9Z, 14E-octadecadienoic-, 12,15,16-trihydroxy-9Z, 13E-octadecadienoic-, 9,10,13-trihydroxy-HE, 15Z-octadecadienoic-, and 12,13,16-trihydroxy-9,14Z-octadecadienoic acid), isolated from Bryonia alba L. roots, were found to exhibit antiatherosclerotic (reducing atherosclerotic manifestations) effects as studied in the cell culture obtained from atherosclerotic plaques of the human aorta. TFA, in a concentration range of 10(-8)-10(-4) M, reduced the total cholesterol content to a higher extent than nifedipine, and inhibited the [(3)H]-thymidine incorporation into the cultivated cells. The experiments with deendothelized rabbit aorta also demonstrated that TFA exhibit an antiatherogenic (preventive) effect resulting in a decreased intima thickness and restricted adhesion of blood cells to the surface of the vessel lumen.
ISSN:0944-7113
DOI:10.1016/S0944-7113(11)80029-2